Uterine Artery Embolization (UAE) for Fibroid Treatment – Results of the 7th Radiological Gynecological Expert MeetingArticle in several languages: English | deutsch
28 February 2019
19 March 2019
28 May 2019 (online)
Uterine artery embolization (UAE) is a safe and effective organ sparing treatment for fibroid-related symptoms based on a broad range of published evidence including randomized-controlled trials. Indication for treatment by means of UAE are symptomatic uterine fibroids. UAE is an alternative to surgical and medical treatment for uterine fibroids as well treatment by MRgFUS. This consensus paper covers the structural prerequisites, the criteria for technical and clinical success, contraindications, side effects and complications as well as the role of UAE treatment in women wishing to conceive and gives guidance on radiation safety measures and clinical follow-up.
The therapeutic aim of UAE for fibroids is the improvement (alleviation) or disappearance of fibroid-related symptoms
The indication for UAE treatment is based on a gynecological examination incl. ultrasound performed by a specialist
UAE is an alternative to surgical or medical therapy of fibroids as well as fibroid treatment by means of MRgFUS, independently of the size and number of fibroids (leiomyoma) or previous surgery
The decision to offer UAE should be based on the wish of the patient and having regard to treatment alternatives, their success rates, limitations and side effects
For women with uterine fibroids who wish to conceive the role of UAE as a treatment options is still not clarified based on the current state of knowledge
Kröncke T, David M. Uterine Artery Embolization (UAE) for Fibroid Treatment: Results of the 7th Radiological Gynecological Expert Meeting. Fortschr Röntgenstr 2019; 191: 630 – 634
* For the participants of the consensus meeting 2019 listed in alphabetical order at the end of the article.